Henry Levy joined Clarivate in May 2023 as President, Life Sciences & Healthcare (LS&H). He leads the teams focused on developing solutions that enable life sciences and healthcare companies and providers to create a heathier tomorrow by connecting them to transformative intelligence and data technology to improve patient lives.
With over 25 years of experience, Henry is the author of multiple articles on drug development and technology trends and a frequent speaker at industry forums. Prior to Clarivate, Henry held several roles at Veeva Systems, including Chief Strategy Officer, General Manager for the Clinical Data Management product suite and, most recently, President, Global R&D and Quality. Previously, he was Chief Commercial Officer for PPD, where he defined new models for biopharmaceutical companies to partner with contract research organizations to drive down costs and improve the speed of drug development. Before that, he led Accenture’s global life sciences R&D practice, where he helped 90% of the top 20 biopharmaceutical companies improve through consulting, technology and outsourcing solutions.
He holds a bachelor’s degree in bioengineering from the University of Pennsylvania.